Načítá se...
Osteopontin controls immunosuppression in the tumor microenvironment
Cancer cells evade the immune system through a variety of different mechanisms, including the inhibition of antitumor effector T cells via checkpoint ligand–receptor interaction. Moreover, studies have shown that blocking these checkpoint pathways can reinvigorate the antitumor immunity, thereby pro...
Uloženo v:
| Vydáno v: | J Clin Invest |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society for Clinical Investigation
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6264653/ https://ncbi.nlm.nih.gov/pubmed/30395537 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI124918 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|